Douglas Lorne Arnold

42PUBLICATIONS
111CO-AUTHORS
Neurology and neuromuscular diseasesMedical infection agents (incl. prions)Optical technologyBiologically active moleculesMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Feb 04, 2026
Brain atrophy rates vary with age in relapsing-remitting multiple sclerosis.

Sezgi Kaçar, David R van Nederpelt, Julia R Jelgerhuis

|Dec 27, 2025
Periventricular gradients in axonal and myelin microstructure are present in people with multiple sclerosis having low and high disability.

Hannah R Bernstein, Vladimir Grouza, Joseph S Gati

|Dec 27, 2025
Safety and efficacy of opicinumab in participants with relapsing multiple sclerosis (AFFINITY Part 1): A randomized, controlled, phase 2 trial.

Peter A Calabresi, Gavin Giovannoni, Hans-Peter Hartung

|Nov 05, 2025
Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Final analysis of the DAYBREAK open-label extension trial.

Krzysztof W Selmaj, Lawrence Steinman, Giancarlo Comi

|Aug 20, 2025
AI-driven reclassification of multiple sclerosis progression.

Habib Ganjgahi, Dieter A Häring, Piet Aarden

|Jul 23, 2025
Brain atrophy and associations with long-term disability and cognitive function in participants with relapsing multiple sclerosis treated with ozanimod: Results from phase 3 and open-label extension trials.

Jeffrey A Cohen, Douglas L Arnold, John DeLuca

Pageof 7

Frequent Collaborators

11 joint publications

Ludwig Kappos

6 joint publications

Colm Elliott

5 joint publications

Giulia Fadda

5 joint publications

Bruce Ac Cree